Aurobindo Pharma Ltd

Common Name

Aurobindo Pharma

Country

India

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

27,707

Ticker

AUROPHARMA

Exchange

NATIONAL STOCK EXCHANGE OF INDIA

Website

www.aurobindo.com

Description

Aurobindo Pharma Ltd. is a prominent pharmaceutical company engaged in the manufacturing and marketing of a broad range of generic pharmaceuticals and active pharmaceutical ingredients (APIs). The pri... Show more

Financial Statements of Aurobindo Pharma

Below are the financial statements of Aurobindo Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in billions of INR	2024	2023
Property, plant and equipment	112.61^a	75.43^a
Capital work-in-progress	27.39^a	44.96^a
Right-of-use assets	2.85^a	4.52^a
Goodwill	5.95^a	5.96^a
Other intangible assets	23.52^a	24.32^a
Intangible assets under development	11.29^a	8.94^a
Investments in associates and joint ventures	0.95^a	0.9^a
Financial assets	—	—
Investments	2.27^a	3.02^a
Loans	0.06^a	0.06^a
Trade receivables	0^a	0^a
Other financial assets	3.51^a	1.5^a
Deferred tax assets (net)	12.13^a	6.77^a
Non current tax assets (net)	3.83^a	2.89^a
Other non-current assets	2.3^a	4.17^a
Total non-current assets	208.66^a	183.44^a
Inventories	98.08^a	85.11^a
Investments	0.51^a	1.51^a
Trade receivables	48.17^a	44.66^a
Cash and cash equivalents	33.93^a	43.96^a
Bank balances other than (iii) above	28.85^a	16.88^a
Loans	0.13^a	0.12^a
Other financial assets	2.63^a	2.9^a
Current tax assets (net)	0.06^a	0.76^a
Other current assets	25.36^a	18.69^a
Total current assets	237.72^a	214.6^a
Assets held for sale	4.34^a	0.86^a
Total assets	450.72^a	398.9^a
Equity share capital	0.59^a	0.59^a
Other equity	297.84^a	267.81^a
Equity attributable to owners of the company	298.43^a	268.4^a
Non-controlling interest	0.08^a	0.12^a
Total equity	298.51^a	268.52^a
Financial liabilities	—	—
Borrowings	21.35^a	6.19^a
Lease liabilities	2.53^a	3.22^a
Other financial liabilities	0.15^a	0.13^a
Provisions	2.26^a	1.73^a
Deferred tax liabilities (net)	3.57^a	3.9^a
Other non-current liabilities	0.36^a	0.29^a
Total non-current liabilities	30.22^a	15.44^a
Borrowings	41.8^a	42.43^a
Lease liabilities	0.8^a	1.03^a
Trade payables	—	—
Total outstanding dues of micro enterprises and small enterprises	0.79^a	0.62^a
Total outstanding dues of creditors other than micro enterprises and small enterprises	43.75^a	38.09^a
Other financial liabilities	21.02^a	17.21^a
Other current liabilities	8.77^a	11.43^a
Provisions	2.57^a	2.01^a
Current tax liabilities (net)	2.49^a	2.12^a
Total current liabilities	121.99^a	114.94^a
Total equity and liabilities	450.72^a	398.9^a

Verified Sources Behind Aurobindo Pharma’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Aurobindo Pharma’s data sources below and access millions more through our Disclosure Search.

a. Aurobindo Pharma's Integrated Report 2024

Trace every data point back to Aurobindo Pharma’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Aurobindo Pharma Ltd

Financial Statements of Aurobindo Pharma

Verified Sources Behind Aurobindo Pharma’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Dr Reddy's Laboratories Ltd

Alkem Laboratories Ltd

Torrent Pharmaceuticals Ltd

Sun Pharmaceutical Industries Ltd

Lupin Ltd

Cipla Ltd